A Patented Blend of Vitamin B-12, Resveratrol, EGCG (green tea extract) and Melatonin with proven scientific results

Alzyn Bottle

A Breakthrough in Brain Health

As we age, our digestive system becomes less efficient at absorbing critical nutrients your brain needs. Alzyn solves this problem with our patented combination of four safe and scientifically proven compounds that are absorbed through the skin or by ingesting our patented sublingual tablet.

What is Alzyn? Alzyn for Brain Health is a sublingual tablet that contains precise amounts of Vitamin B12, Melatonin, EGCG, and Resveratrol. Each of these compounds helps to either reduce risks or maintain the aging brain’s defenses to stay healthy, protect memory, increase mental clarity, and slow cognitive decline.

Brain Health Support

At Alzyn, we believe that in order to perform better and fell our best, we must take care of ourselves from the inside out. That’s why we’re committed to helping support your brain health and prevent against cognitive decline with a combination of four critical nutritional compounds.

Icon Vitamin B-12

Vitamin B-12 is required for proper red blood cell formation, neurological function, and DNA synthesis. B12 is particularly essential in long-term brain health, too, helping to fight off degenerative diseases.

Icon Melatonin

Melatonin has strong neuroprotective and immunity-boosting effects, especially under the conditions of elevated oxidative stress or significant neural inflammation.

Icon Melatonin

EGCG epigallocatechin-3-gallate (EGCG), the active ingredient in green tea, is a potent antioxidant. Now researchers have discovered how China’s favorite drink’s chemical properties affect brain cells’ generation, providing benefits for memory and spatial learning.

Icon Resveratrol

Resveratrol, or trans-Resveratrol, is a plant-based compound found in grapes and other foods. It has been shown to slow cognitive decline, support immunity and overall health, and promote healthy aging.

The Alzyn Benefit to the Consumer

"Inflammation, oxidation, and formation of toxic peptide and protein species have been demonstrated to lead to a decline in brain function and memory loss associated with aging. Each of the Alzyn compounds provides nutrients that enable the body to alleviate these negative changes in age-related brain function."
Dr. Ewa Bienkiewicz, PhD
Research Associate Professor at Florida State University College of Medicine

Dr. Ewa Bienkiewicz and Alzyn collaborate to protect the health of the aging brain

Dr. Ewa Bienkiewicz is a researcher at the Florida State University College of Medicine with a deep personal interest in brain function decline among the aging. Following years of study, she determined that any solution must beneficially impact multiple biological factors in the brain.

After extensive research, she determined that four naturally occurring nutrients, acting in concert, had a favorable impact on five critical factors associated with cognitive decline. She published the results of her research in a major scientific journal. These four nutrients, however, cannot be well absorbed through ordinary digestion in most people over the age of 50.

Based on her findings, ALZYN, LLC (the company) was formed and secured exclusive rights to Dr. Bienkiewicz’s science. Working in concert with a private research group, Langford Research Institute, Alzyn created the solution for getting the essential nutrients into the system. A specially formulated liquid compound enables the combination of nutrients to enter the body while bypassing the digestive tract. The results were confirmed through two series of testing in laboratory animals.

Based on those results, Alzyn has become a product with unique and proven properties to protect aging brain cells.

Dr. Ewa Bienkiewicz

The Science Behind Alzyn

Alzyn is the result of research by Dr. Ewa Bienkiewicz, PhD, Research Associate Professor and Director of the Protein Biology Laboratory at Florida State University College of Medicine. Her team’s research was published in a major scientific journal.